R-Japan Co., Ltd., a Japanese affiliate of Nature Cell, announced on November 25 that stem cell therapy in Japan has begun, using the adult stem cell technology developed by Korea’s Biostar Stem Cell Research Institute (President Dr. Ra Jeong-chan).
Read more
We’ve finally acquired approval for stem cell therapy (regenerative medicine) from the Japanese government.
Read more
On November 11, R-Japan Co., Ltd., an affiliate of Nature Cell in Japan, announced that its medical institution partner, Nishihara Clinic, acquired approval for stem cell treatment of critical limb ischemia (CLI) and Buerger’s disease from the Japanese Ministry of Health, Labour and Welfare (MHLW), based on a project initiated by the Biostar Stem Cell Research Institute.
Read more
On October 8, the Biostar Stem Cell Research Institute, jointly operated by Nature Cell and R Bio, announced that it has completed the application process for acquiring approval for treating degenerative arthritis with regenerative medicine.
Read more
The Biostar Stem Cell Research Institute, jointly run by Nature Cell and R Bio, announced on September 18 that it has successfully developed the method of separating and culturing stem cells from urine, using independently developed technology.
Read more
On September 8, the Biostar Stem Cell Research Institute, co-operated by Nature Cell and R Bio, announced that it has completed the application process for acquiring approval of the regenerative medicine treatment method for Buerger’s disease through its medical institution partner in Japan.
Read more
Biostar Stem Cell Research Institute
08506
305, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul
R Bio Co.,Ltd.
+82 -2-858-8021~5
Most Commented